However, there may be an additional hormonal factor that contributes to the more severe AAA phenotype in postmenopausal women, which is in line with newly gained insights of the role of FSH in postmenopausal osteoporosis and CVD. This evidence concerns the gene BRD2 and triple-A syndrome.